Abstract
Although the promiscuous nature of G16 allows it to interact with numerous G protein-coupled receptors, several Gi-linked receptors are incapable of activating phospholipase C via G16. A series of chimeras between Gα16 and Gαz were constructed and assayed for their ability to mediate receptor-induced stimulation of phospholipase C. Two Gα16/z chimeras harboring 25 or 44 Gαz-specific sequences at their C termini (named 16z25 and 16z44) were capable of responding to 14 different Gi-coupled receptors tested, including those that were either unable to associate with Gα16 (melatonin Mel1c) or activate Gα16 weakly (μ-opioid and type 1 somatostatin). Agonist-induced stimulation of phospholipase C was more efficiently mediated (higher maximal and lower EC50 value) by 16z44 than by Gα16. Both 16z25 and 16z44 were also coupled to Gs- and Gq-linked receptors. Incorporation of Gαz sequence at the N terminus of Gα16 did not further enhance the ability of the chimeras to interact with Gi-coupled receptors. Expression of the various chimeras was verified by immunodetection and functional analysis of their constitutively activated mutants. These results show that the incorporation of α4/β6 and α5 regions of Gαz into a Gα16 backbone can improve the recognition of Gi-coupled receptors. Gα16/zchimeras with expanded capability to interact with Gi-linked receptors may be used to link orphan receptors to the stimulation of phospholipase C.
Footnotes
-
Send reprint requests to: Dr. Yung H. Wong, Department of Biology, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China. E-mailboyung{at}ust.hk
-
↵1 Present address: Center for Biotechnology, NorthWestern University, 1801 Maple Avenue, Evanston, IL 60201.
-
This work was supported by the Research Grants Council of Hong Kong (HKUST 6096/98M).
- Abbreviations:
- GPCR
- G protein-coupled receptor
- DPDPE
- [d-Pen2,d-Pen5]enkephalin
- PLC
- phospholipase C
- PCR
- polymerase chain reaction
- PTX
- pertussis toxin
- IP
- inositol phosphates
- DMEM
- Dulbecco's modified Eagle's medium
- Received April 22, 1999.
- Accepted September 3, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|